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Single-crystal X-ray study
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In the title molecule, C22H19NO2S, the thiazolidinone ring
exhibits a flattened envelope conformation. The methoxy-
phenyl and biphenyl substituents are in pseudo-equatorial and
pseudo-axial orientations, respectively, with respect to the
thiazolidinone ring.
Comment
The thiazolidin-4-one ring system exists in a number of
biologically active compounds which exhibit anticonvulsant
(Ragab et al., 1997), hypnotic (Chaudhary et al., 1975), anti-
inflammatory (Vigorita et al., 2001), antiproteolytic (Chaud-
hari et al., 1976) and antituberculous (Babaoglu et al., 2003)
properties. The usual conformations of the thiazolidin-4-one
ring are envelope or half-chair (Diurno et al., 1992). The
structural and conformational features of thiazolidin-4-one
derivatives are essential in the study of their structure–activity
relationships. As part of our continuing research in the
synthesis of nitrogen-containing biologically active hetero-
cyclic compounds (Ravikumar et al., 2003; Basappa et al.,
2003), the title compound, (I) (Fig. 1), has been synthesized
and we present its crystal structure here.
The thiazolidinone ring in (I) exhibits a flattened envelope
conformation, where atom S14 is displaced by 0.3918 (8) A˚
from the mean plane of atoms C15/C16/N18/C13. This
conformation may be caused by the different steric hindrance
of the substituents attached to atoms N18 and C13. These
substituents, viz. methoxyphenyl and biphenyl, respectively,
show pseudo-equatorial and pseudo-axial orientations,
respectively, with respect to the thiazolidinone ring. Most of
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the bond lengths and angles (Table 1) have normal values. The
crystal packing (Fig. 2) is stabilized by van der Waals forces.
A detailed study of the biological activity of (I) is under-
way.
Experimental
4-Methoxyaniline (5 g, 1 mol), 4-biphenylcarboxaldehyde (7.39 g,
1.0 mol) and anhydrous -ferrite (12.96 g, 2 mol) were refluxed with
constant stirring in dry benzene for 30 min, after which thioglycolic
acid (2.82 ml, 1 mol) was added to the reaction mixture. Reflux and
stirring were continued for another 3 h. The reaction was monitored
by thin-layer chromatography (RF = 0.56). After completion of the
reaction, a red–brown amorphous solid, Fe2O32H2O/FeO(OH), was
removed by filtration. The filtrate was concentrated to dryness under
reduced pressure. The product was confirmed by spectroscopic
characterization (yield 78, m.p. 415–417 K). Anaylsis calculated:
C 73.10, H 5.29, N 3.87, S 8.87%; found: C 73.17, H 5.22, N 3.89,
S 8.86%. 1 g of (I) was taken up in 15 ml of methanol. Charcoal (1 g)
was added and the solution was heated for 2 to 3 min. The hot
solution was filtered through a Whatmann 42 filter paper. The solu-
tion was kept in a slightly opened conical flask. Crystals were
obtained after a few days.
Crystal data
C22H19NO2S
Mr = 361.44
Orthorhombic, Pbc21
a = 6.287 (5) A˚
b = 13.248 (9) A˚
c = 22.250 (9) A˚
V = 1853.2 (2) A˚3
Z = 4
Dx = 1.295 Mg m
3
Mo K radiation
Cell parameters from 5948
reflections
 = 2.4–32.5
 = 0.19 mm1
T = 293 (2) K
Block, pale yellow
0.35  0.2  0.2 mm
Data collection
DIPLabo 32001 diffractometer
! scans
5948 measured reflections
5640 independent reflections
4167 reflections with I > 2(I)
Rint = 0.016
max = 32.5

h = 9 ! 9
k = 19 ! 19
l = 27 ! 27
Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.045
wR(F 2) = 0.110
S = 1.09
5640 reflections
237 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0375P)2
+ 0.2616P]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.19 e A˚
3
min = 0.22 e A˚3
Extinction correction: SHELXL97
Extinction coefficient: 0.0111 (13)
Absolute structure: Flack (1983),
with 2218 Friedel pairs
Flack parameter: 0.40 (8)
Table 1
Selected geometric parameters (A˚, ).
S14—C13 1.8261 (19)
S14—C15 1.778 (3)
O17—C16 1.222 (2)
O25—C22 1.367 (3)
O25—C26 1.413 (4)
N18—C13 1.465 (2)
N18—C16 1.355 (2)
N18—C19 1.442 (2)
C13—S14—C15 92.75 (10)
C22—O25—C26 118.21 (19)
C13—N18—C16 117.21 (15)
C13—N18—C19 119.77 (14)
C16—N18—C19 120.82 (15)
S14—C13—N18 105.11 (12)
S14—C13—C10 109.94 (14)
N18—C13—C10 114.27 (14)
S14—C15—C16 108.15 (15)
O17—C16—N18 124.48 (17)
O17—C16—C15 123.18 (18)
N18—C16—C15 112.33 (17)
N18—C19—C20 119.71 (16)
N18—C19—C24 120.52 (16)
O25—C22—C21 115.40 (18)
O25—C22—C23 124.62 (19)
The H atoms were placed at idealized positions and allowed to ride
at the parent C atoms, with C—H = 0.96 A˚ and Uiso(H) = 1.2Ueq(C).
The value of the Flack parameter (Flack, 1983) indicates an inversion
twin. Pbc21 is a unconventional setting of Pca21. Since the transfor-
mation to the conventional setting did not yield a better solution,
Pbc21 was retained.
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Figure 1
View of (I), with 50% probability displacement ellipsoids.
Figure 2
The crystal packing in (I), viewed down the a axis.
Data collection: XPRESS (MacScience, 2002); cell refinement:
SCALEPACK (Otwinowski & Minor, 1997); data reduction:
DENZO (Otwinowski & Minor, 1997) and SCALEPACK;
program(s) used to solve structure: SHELXS97 (Sheldrick, 1997);
program(s) used to refine structure: SHELXL97 (Sheldrick, 1997);
molecular graphics: PLATON (Spek, 2003); software used to prepare
material for publication: SHELXL97.
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